A Phase 2, Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of AT-02 (NCT05951049)
AT02-003
This trial is No longer recruiting
Registration number NCT05951049
Program & service
This trial is being run with the Heart & Lung service, and as part of the Cardiology program.
Trial phase
Phase 2
Trial participation type
This trial has been designed for the Clinical Research of a Drug.
Principal investigator
Associate Professor James Hare
More information
To find out more about this clinical trial, please review full details on the ANZCTR website.
View on ANZCTR